These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7366630)

  • 1. Thymosin alpha 1 in myasthenia gravis.
    Dalakas MC; Engel WK; McClure JE; Goldstein AL
    N Engl J Med; 1980 May; 302(19):1092-3. PubMed ID: 7366630
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential role of thymosin in the treatment of autoimmune diseases.
    Goldstein AL; Zatz MM; Low TL; Jacobs R
    Ann N Y Acad Sci; 1981; 377():486-95. PubMed ID: 6462093
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preliminary observation of the effect of thymosin on myasthenia gravis].
    Zhang ZX; Ren YL; Tan MX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Oct; 6(5):366-9. PubMed ID: 6241090
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of myasthenia gravis with immune drugs and immunological observations on 31 cases (author's transl)].
    Yu CZ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Feb; 14(1):19-22. PubMed ID: 7307782
    [No Abstract]   [Full Text] [Related]  

  • 5. Thymosin for immunodeficiency diseases and cancer.
    Goldstein AL; Rossio JL
    Compr Ther; 1978 Feb; 4(2):49-57. PubMed ID: 624213
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of thymosin (fraction V) on adjuvant diseases in rats.
    Rovenský J; Grimová J; Pekárek J; Korcáková L
    Thymus; 1981 Jun; 3(1):51-3. PubMed ID: 7268832
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic reconstitution of patients with primary immunodeficiency diseases and cancer after treatment with thymosin.
    Goldstein AL; Thurman GB; Rossio JL; Costanzi JJ
    Transplant Proc; 1977 Mar; 9(1):1141-4. PubMed ID: 325742
    [No Abstract]   [Full Text] [Related]  

  • 8. [Regular trisomy 21 and combined immunodeficiency. Ineffectiveness of thymosin].
    Calvani M; Aiuti F; Felici N; D'Amelio R; Picchio E
    Minerva Pediatr; 1979 Dec; 31(23):1691-7. PubMed ID: 162325
    [No Abstract]   [Full Text] [Related]  

  • 9. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
    Franchi F; Segni G; Stabile A; Ammirati P; Aiuti F
    Minerva Pediatr; 1978 Apr; 30(8):609-13. PubMed ID: 661768
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of thymosin application upon radiation sickness in mice.
    Vávrová J; Petýrek P
    Folia Biol (Praha); 1976; 22(5):320-9. PubMed ID: 992155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pilot-trial of treatment of leprosy by pig's thymosin combined with dapsone (author's transl)].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Sep; 3(3):198-200. PubMed ID: 6459183
    [No Abstract]   [Full Text] [Related]  

  • 12. [Formation of immune rosettes by the cells of certain lymphoid system formations after treatment with thymosin].
    Selezneva TN; Kamenets LIa; Grinevich IuA
    Fiziol Zh (1978); 1979; 25(6):730-4. PubMed ID: 315887
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunostimulation with preparation TFX in lymphoblastic leukemia].
    Chmielewska D; Traczewska M; Ochocka M
    Pediatr Pol; 1980 Nov; 55(11):1213-9. PubMed ID: 6936711
    [No Abstract]   [Full Text] [Related]  

  • 14. Thymosin treatment of children with primary immunodeficiency disease.
    Wara DW; Ammann AJ
    Transplant Proc; 1978 Mar; 10(1):203-9. PubMed ID: 305674
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy of cancer with thymosin.
    Rossio JL; Goldstein AL
    World J Surg; 1977 Sep; 1(5):605-16. PubMed ID: 602234
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thymus hormones: chemical characteristics and biological properties].
    Astaldi A
    Pathologica; 1976; 68(975-976):1-8. PubMed ID: 1012782
    [No Abstract]   [Full Text] [Related]  

  • 17. Thymosin: basic properties and clinical application in the treatment of immunodeficiency diseases and cancer.
    Marshall GD; Thurman GB; Low TL; Goldstein AL
    Recent Results Cancer Res; 1980; 75():100-5. PubMed ID: 6262885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Principles of using immunostimulants for correction of immunologic deficiency in pollinosis].
    Kravchuk GP; Zabolotnyĭ DI; Begunova TI
    Vestn Otorinolaringol; 1979; (6):53-6. PubMed ID: 316218
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunocorrective therapy in the complex of resuscitative measures to treat the severe form of tetanus].
    Treshchinskiĭ AI; Mozhaev GA; Svirgunenko IuP; Zakorzhevskiĭ IB; Mozhaeva EB
    Anesteziol Reanimatol; 1982; (3):31-4. PubMed ID: 7114563
    [No Abstract]   [Full Text] [Related]  

  • 20. Thymosin therapy in the DiGeorge syndrome.
    Barrett DJ; Wara DW; Ammann AJ; Cowan MJ
    J Pediatr; 1980 Jul; 97(1):66-71. PubMed ID: 7381650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.